http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104225677-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
| filingDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104225677-B |
| titleOfInvention | Cross-linked-hyaluronic acid cell scaffold material and its preparation method and application |
| abstract | The present invention relates to a kind of cross-linked-hyaluronic acid cell scaffold material and its preparation method and application.Cross-linked-hyaluronic acid timbering material of the present invention is by one group of polymer hyaluronic acid salt and one group of crosslinked acquisition of low molecular weight hyaluronic acid salt, and the hyaluronic acid disaccharidase molecular ratios participating in crosslinking is 0.5%～20%, the expansion rate 80%～110% in isosmotic solution.The preparation method of cell scaffold material of the present invention includes twice lyophilization step, will be mixed with the hyaluronate molding of cross-linking agent for the first time, after reacting by heating, adds water-swellable for gel, again lyophilization acquisition porous support materials.This support has abundant hole, certain mechanical strength and pore size, good water absorption and biocompatibility, can be as tissue engineering cell scaffold for promoting the reparation of cartilage injury, it is possible to be used as preparation hemostasis, the material of anti. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2710074-C1 |
| priorityDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 277.